Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
5 Assignments
0 Petitions
Accused Products
Abstract
Compositions and methods for the treatment, reduction and/or prevention of cardiovascular diseases and disorders are described. Individuals at high risk for developing or having cardiovascular disease or disorder may be treated with an effective dose of a polymethoxyflavone including limocitrin derivatives, quercetin derivatives, naturally occurring polymethoxyflavones, tocotrienols, and mixtures of these compounds.
-
Citations
32 Claims
-
1-12. -12 (cancelled)
-
13. An oral pharmaceutical dosage form comprising at least one pharmaceutically acceptable excipient and a polymethoxylated flavones.
-
14. The dosage form of claim 13, further comprising tocotrienols.
-
15. The dosage form of claim 13, further comprising liminoids.
-
16. The dosage form of claim 13, wherein the dosage form is a solid preparation.
-
17. The dosage form of claim 16, wherein the dosage form is a tablet or a capsule.
-
18. The dosage form of claim 17, wherein the tablet or capsule contains a predetermined amount of the mixture as solids, gelatins, suspensions or emulsions.
-
19. The dosage form of claim 13, wherein the pharmaceutically acceptable excipient is a gel phase carrier.
-
20. The dosage form of claim 13, wherein the pharmaceutically acceptable excipient comprises calcium carbonate, calcium phosphate, a sugar, a starch, a cellulose derivative, gelatin and a polymer.
-
21. The dosage form of claim 13, wherein the dosage form is a liquid solution or emulsion.
-
22. A method of lowering serum cholesterol, Apo B or LDL cholesterol comprising (i) preparing an oral pharmaceutical dosage form comprising at least one pharmaceutically acceptable excipient and polymethoxylated flavones;
- and (ii) orally administering an amount of said dosage form to provide about 1-1000 mg/day polymethoxylated flavones and about 1-1000 mg/day tocotrienols.
-
23. The method of claim 22, wherein the dosage form further comprises tocotrienols and wherein the administration provides an amount of said dosage form to provide about 1-1000 mg/day tocotrienols.
-
24. The method of claim 22, comprising orally administering an amount of said dosage form to provide about 1-100 mg/day tocotrienols
-
25. The method of claim 22, wherein the dosage form is a solid preparation.
-
26. The method of claim 22, wherein the dosage form is a tablet or a capsule.
-
27. The method of claim 26, wherein the tablet or capsule contains a predetermined amount of the mixture as solids, gelatins, suspensions or emulsions.
-
28. The method of claim 22, wherein the pharmaceutically acceptable excipient is a gel phase carrier.
-
29. The method of claim 22, wherein the pharmaceutically acceptable excipient comprises calcium carbonate, calcium phosphate, a sugar, a starch, a cellulose derivative, gelatin and a polymer.
-
30. The method of claim 22, wherein the dosage form is a liquid solution or emulsion.
-
31. A method of treating a neoplastic disease comprising (i) preparing an oral pharmaceutical dosage form comprising at least one pharmaceutically acceptable excipient and flavonoids;
- and (ii) orally administering an amount of said dosage form effective to treat a neoplastic disease.
-
32. The method of claim 31, wherein the dosage form further comprises liminoids.
Specification